Breast Cancer
US Oncology Research Network Participates in Phase III Follow-up Study To BiPars Investigational Cancer Drug BSI-201
Published in Women's Health Law Weekly, August 23rd, 2009
Joyce O'Shaughnessy, M.D., co-chair of the US Oncology Breast Cancer Research Committee, associate director for clinical research for US Oncology and co-director of the Breast Cancer Research Program at Baylor-Charles A. Sammons Cancer Center and Texas Oncology, a US Oncology affiliate in Dallas, Texas, will lead the study as a follow-up to the Phase II...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Breast Cancer
Study data from N. Moumjid and co-authors update knowledge of breast cancer - Knights of Columbus
'Health Care Reform Must be Abortion-Free,' says Supreme Knight - Pennsylvania Treasury Department
Treasurer McCord Assists PA Women Entrepreneurs' Advance During National Economic Recovery - Violence Policy Center
Pittsburgh Fitness Center Attack Only Most Recent Mass Shooting Committed by Concealed Handgun Permit Holder - Academy of Art University
The Academy of Art University Applauds Release of Euna Lee and Laura Ling - Adenocarcinoma
Findings from Methodist Hospital, Department of Pathology advance knowledge in adenocarcinoma - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
